SHERLOCK 3CG™ Diamond Tip Confirmation System

Stopped early

Conditions studied: Indication for Peripheral Intravenous Catheterization, Atrial Flutter, Premature Atrial Contraction, Premature Ventricular Contraction, Premature Junctional Contraction, Tachycardia, Atrioventricular Block, Bundle-Branch Block

In brief

This study is a single-arm, prospective, multi-center study to assess clinical performance of the SHERLOCK 3CG™ Diamond Tip Confirmation System (TCS) with MODUS II software for confirming correct tip position of peripherally inserted central catheters (PICCs) in adult subjects with altered cardiac rhythm.

Key facts

Study ID

NCT03288766

Run by

C. R. Bard

People needed

232

Starts

2018-04-19

Expected to finish

2021-06-15

Last updated by the study team

2021-10-20

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, ≥ 21 years of age with altered cardiac rhythm (no recognizable P-wave on standard ECG) with diagnosis of specific arrhythmia type or identification of pacemaker driven rhythms as defined below:
• Atrial fibrillation with history of diagnosis per 12-lead ECG in medical record or diagnosed via bedside telemetry by study team RN at assessment, or
• All other arrhythmias (including but not limited to atrial flutter, PAC, PVC, PJC, tachycardia, AV Block, BB Block) with history of diagnosis per 12-lead ECG in medical record or diagnosed via bedside telemetry by cardiac unit RN at assessment, or retrospectively by site cardiologist, or
• Pacemaker driven rhythm with temporary or permanent pacemaker device in place;
• Subject requires PICC placement as part of standard of care;
• Subject or Legally Authorized Representative (LAR) has signed an Informed Consent Form (ICF).

You may not qualify if…

• Subject has a contraindication to PICC placement as listed in the Instructions for Use (IFU) to include:
• The presence of bacteremia or septicemia (known or suspected),
• The patient's body size is insufficient to accommodate the size of the implanted device,
• The patient is known or is suspected to be allergic to materials contained in the device,
• Past irradiation of prospective insertion site,
• Previous episodes of venous thrombosis or vascular surgical procedures at the prospective placement site,
• Local tissue factors will prevent proper device stabilization and/or access;
• Subjects who previously had a PICC in place and require a PICC exchange;
• Subject has presence of active resting tremor (i.e. Parkinson's, Multiple Sclerosis, etc.) deemed by Investigator to have potential impact on procedure accuracy;
• Subjects who are pregnant or think they may be pregnant.

Where it is running

• Summerlin Hospital and Medical Center — Las Vegas, Nevada, United States
• Moses Cone Hospital — Greensboro, North Carolina, United States
• Vidant Medical Center — Greenville, North Carolina, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Providence Sacred Heart Medical Center — Spokane, Washington, United States
• J.W. Ruby Memorial Hospital — Morgantown, West Virginia, United States
• Sunshine Coast University Hospital — Birtinya, Queensland, Australia
• Fiona Stanley Hospital — Murdoch, Western Australia, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.